Celdara Medical Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $11.1M

  • Investors
  • 9

Celdara Medical General Information

Description

Provider of academic and early-stage innovations services intended to build potential medical companies. The company partners with inventors and their institutions, providing the developmental, financial, and business acumen required to bridge discovery and profitability with robust funding options, and a diverse and high-impact programmatic pipeline, enabling companies with expertise and insights in drug development and clinical practice.

Contact Information

Website
www.celdaramedical.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Corporate Office
  • 16 Cavendish Court
  • Dartmouth Regional Technology Center
  • Lebanon, NH 03766
  • United States
+1 (617) 000-0000
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 16 Cavendish Court
  • Dartmouth Regional Technology Center
  • Lebanon, NH 03766
  • United States
+1 (617) 000-0000

Celdara Medical Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celdara Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Grant 08-Aug-2017 $11.1M Completed Startup
19. Grant 25-Apr-2022 00.000 Completed Pre-Clinical Trials
18. Grant 08-Sep-2021 00000 Completed Pre-Clinical Trials
17. Grant 01-Jan-2021 00000 Completed Pre-Clinical Trials
16. Debt - PPP 30-Apr-2020 00000 Completed Pre-Clinical Trials
15. Grant 01-May-2019 00000 Completed Pre-Clinical Trials
14. Grant 01-Jan-2019 00000 Completed Pre-Clinical Trials
13. Grant 03-Nov-2018 00.000 Completed Pre-Clinical Trials
12. Angel (individual) Completed Pre-Clinical Trials
11. Grant 01-Sep-2018 $1.45M Completed Pre-Clinical Trials
To view Celdara Medical’s complete valuation and funding history, request access »

Celdara Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of academic and early-stage innovations services intended to build potential medical companies. The company par
Drug Discovery
Lebanon, NH
24 As of 2024
0000000000

00000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt i
0000 000000000
Pittsburgh, PA
0 As of 0000
00.000
0000000000 0 00.000

000000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
0000 000000000
Salt Lake City, UT
000 As of 0000
00.000
00000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celdara Medical Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sharp Therapeutics Venture Capital-Backed Pittsburgh, PA 0 00.000 0000000000 0 00.000
Recursion Pharmaceuticals Formerly VC-backed Salt Lake City, UT 000 00.000 00000000 00.000
Merck & Co. Corporation Rahway, NJ 00000 0000 000000000 - 0000
PureTech Health Formerly VC-backed Boston, MA 00 00000 000000&0
Ability Pharma Private Equity-Backed Barcelona, Spain 00 000.00 0000000 0000 000.00
You’re viewing 5 of 12 competitors. Get the full list »

Celdara Medical Patents

  • 8

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

Celdara Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200369773-A1 Cellular based therapies targeting disease-associated molecular mediators of fibrotic, inflammatory and autoimmune conditions Pending 18-Aug-2017 00000000000 0
US-20190336534-A1 Chimeric antigen receptors targeting tim-1 Active 13-Jan-2017 000000000
EP-3568416-A1 Chimeric antigen receptors targeting tim-1 Pending 13-Jan-2017 000000000
US-11541076-B2 Chimeric antigen receptors targeting tim-1 Active 13-Jan-2017 000000000 00
EP-3568416-A4 Chimeric antigen receptors targeting tim-1 Pending 13-Jan-2017 A61K35/17 0
To view Celdara Medical’s complete patent history, request access »

Celdara Medical Executive Team (4)

Name Title Board Seat
Jake Reder Ph.D Co-Founder, Chief Executive Officer & Board Member
Julie Coleman Ph.D Executive Director
Paul Guyre Ph.D Vice President of Research & Discovery & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Celdara Medical Board Members (8)

Name Representing Role Since
Eric Achtmann Self Director 000 0000
Jake Reder Ph.D Celdara Medical Co-Founder, Chief Executive Officer & Board Member 000 0000
Kennett Burnes Self Chairman 000 0000
Lita Nelsen Self Director 000 0000
Paul Guyre Ph.D Celdara Medical Vice President of Research & Discovery & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Celdara Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celdara Medical Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government 000 0000 000000 0
National Institute of General Medical Sciences Government 000 0000 000000 0
National Institute for Allergy and Infectious Disease Government 000 0000 000000 0
National Institute of Diabetes and Digestive and Kidney Diseases Government 000 0000 000000 0
National Institute on Drug Abuse (NIDA) Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Celdara Medical FAQs

  • When was Celdara Medical founded?

    Celdara Medical was founded in 2008.

  • Who is the founder of Celdara Medical?

    Jake Reder Ph.D and Michael Fanger Ph.D are the founders of Celdara Medical.

  • Who is the CEO of Celdara Medical?

    Jake Reder Ph.D is the CEO of Celdara Medical.

  • Where is Celdara Medical headquartered?

    Celdara Medical is headquartered in Lebanon, NH.

  • What is the size of Celdara Medical?

    Celdara Medical has 24 total employees.

  • What industry is Celdara Medical in?

    Celdara Medical’s primary industry is Drug Discovery.

  • Is Celdara Medical a private or public company?

    Celdara Medical is a Private company.

  • What is Celdara Medical’s current revenue?

    The current revenue for Celdara Medical is 000000.

  • Who are Celdara Medical’s investors?

    National Institutes of Health, National Institute of General Medical Sciences, National Institute for Allergy and Infectious Disease, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute on Drug Abuse (NIDA) are 5 of 9 investors who have invested in Celdara Medical.

  • Who are Celdara Medical’s competitors?

    Sharp Therapeutics, Recursion Pharmaceuticals, Merck & Co., PureTech Health, and Ability Pharma are some of the 12 competitors of Celdara Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »